Skip to main content

Table 2 Resistance rates of main bacteria pathogens causing pediatric patients with CA-LRTIs to antimicrobial agents during 2011–2016 in Dongguan

From: Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011–2016)

Antimicrobial agent MSSA MRSA E. coli E. coli ESBLs K. pneumonia K. pneumonia ESBLs S. pneumonia P. aeruginosa
Penicillin (10 U) 81.5% 100% 29.0%
Piperacillin (100μg) 59.0% 91.7% 24.2% 100% 21.7%
Ampicillin (10μg) 71.4% 100% 100% 100%
Erythromycin (15μg) 29.6% 81.8% 96.7%
Azithromycin (15μg) 22.2% 83.3%
Clarithromycin (15μg) 34.5% 82.8% 93.3%
Ofloxacin (5μg) 61.2% 6.5% 15.6% 26.9% 3.7% 3.6% 3.2% 10.0%
Gentamicin (10μg) 4.2% 9.4% 36.0% 43.5% 13.8% 13.8% 13.6%
Co-trimoxazole (1.25/23.75μg) 4.0% 13.3% 48.1% 70.8% 75.0% 82.1% 90.0%
Cefazolin (30μg) 0.0% 100% 32.3% 95.7% 36.4% 93.5%
Cefuroxime (30μg) 100% 24.3% 100% 12.9% 97.1%
Ceftriaxone (30μg) 20.0% 96.4% 10.0% 94.1% 7.1%
Ceftazidime (30μg) 2.9% 12.5% 11.1% 67.7% 13.6%
Cefotaxime (30μg) 16.2% 93.1% 13.3% 94.1% 10.0%
Cefepime (30μg) 7.7% 29.6% 0.0% 44.1% 4.2% 4.3%
Vancomycin (30μg) 0.0% 0.0% 0.0%
Imipenem (10μg) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%